11.03.14
HORN Nutraceuticals, a distributor of specialty ingredients, launched two new innovative ingredients for heart health and weight management: OPtain120 and ChalCurb.
A patented combination of onion and pumpkin extracts, OPtain120 is a safe and efficacious ingredient shown to reduce high blood pressure and support a healthy heart, according to the company. Recent clinical studies in the U.S. and Japan on OPtain120 demonstrated systolic blood pressure reduction by 6% and diastolic blood pressure reduction by 4% with evidence of efficacy in as little as five days.
An angiotensin-converting-enzyme (ACE) inhibitor, OPtain120 suppresses production of angiotensin II, which decreases the peripheral resistance and blood volume, thereby reducing blood pressure. Vasodilation also occurs as OPtain120 increases nitric oxide production, therefore increasing the diameter of the blood vessels and reducing blood pressure. Manufactured in Japan by Ryusendo, OPtain120 is a safe, natural product that uses hot water extraction with no harsh chemicals.
Derived from the dried sap of the Ashitaba plant (Angelica keiskei), ChalCurb is manufactured by Japan Bio Science Laboratory and backed by two clinical studies that demonstrated its effect on reducing visceral fat by 10% in just eight weeks. Results were measured via computed tomography (CT) scan. ChalCurb supports leptin and adiponectin production, which affect satiety, lipid metabolism and glucose regulation, the company said. In clinical studies, reduction in subcutaneous fat, weight, body mass index (BMI), waist and hip circumference also were observed. No water or solvents were used in the manufacturing of ChalCurb.
For more information: www.ethorn.com
A patented combination of onion and pumpkin extracts, OPtain120 is a safe and efficacious ingredient shown to reduce high blood pressure and support a healthy heart, according to the company. Recent clinical studies in the U.S. and Japan on OPtain120 demonstrated systolic blood pressure reduction by 6% and diastolic blood pressure reduction by 4% with evidence of efficacy in as little as five days.
An angiotensin-converting-enzyme (ACE) inhibitor, OPtain120 suppresses production of angiotensin II, which decreases the peripheral resistance and blood volume, thereby reducing blood pressure. Vasodilation also occurs as OPtain120 increases nitric oxide production, therefore increasing the diameter of the blood vessels and reducing blood pressure. Manufactured in Japan by Ryusendo, OPtain120 is a safe, natural product that uses hot water extraction with no harsh chemicals.
Derived from the dried sap of the Ashitaba plant (Angelica keiskei), ChalCurb is manufactured by Japan Bio Science Laboratory and backed by two clinical studies that demonstrated its effect on reducing visceral fat by 10% in just eight weeks. Results were measured via computed tomography (CT) scan. ChalCurb supports leptin and adiponectin production, which affect satiety, lipid metabolism and glucose regulation, the company said. In clinical studies, reduction in subcutaneous fat, weight, body mass index (BMI), waist and hip circumference also were observed. No water or solvents were used in the manufacturing of ChalCurb.
For more information: www.ethorn.com